Justification of a medicinal form development based on the api dimethylammonium 3-methyl-2-(2-((e)-styryl)quinazolin-4-ylthio)butanoate with hepatoprotective and antioxidant effects for the needs of military medicine
Česká a slovenská farmacie · 10.06.2026 · 75 (2) · E2-E8
DOI: 10.36290/csf.2026.023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Česká a slovenská farmacie, erschienen am 10.06.2026. Verfasst von Antonina Avramenko und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antioxidants, Quinazolines. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Avramenko, A., Kaplaushenko, A., & Salionov, V. (2026). Justification of a medicinal form development based on the api dimethylammonium 3-methyl-2-(2-((e)-styryl)quinazolin-4-ylthio)butanoate with hepatoprotective and antioxidant effects for the needs of military medicine. Česká a slovenská farmacie, 75(2), E2-E8. https://doi.org/10.36290/csf.2026.023
Vancouver
Avramenko A, Kaplaushenko A, Salionov V. Justification of a medicinal form development based on the api dimethylammonium 3-methyl-2-(2-((e)-styryl)quinazolin-4-ylthio)butanoate with hepatoprotective and antioxidant effects for the needs of military medicine. Česká a slovenská farmacie. 2026;75(2):E2-E8. doi:10.36290/csf.2026.023
BibTeX
@article{Avramenko2026,
author = {Avramenko, Antonina and Kaplaushenko, Andrii and Salionov, Volodymyr},
title = {Justification of a medicinal form development based on the api dimethylammonium 3-methyl-2-(2-((e)-styryl)quinazolin-4-ylthio)butanoate with hepatoprotective and antioxidant effects for the needs of military medicine},
journal = {Česká a slovenská farmacie},
year = {2026},
volume = {75},
number = {2},
pages = {E2--E8},
doi = {10.36290/csf.2026.023}
}
EUVIMED